Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @pacylex
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @pacylex
-
Exciting preclinical data and novel mechanism of action for PCLX-001 positions Pacylex well for 2020. https://buff.ly/2PQg0pw
#cancer#precision#small#molecule#leukemia#AMLpic.twitter.com/o8hCfCWhLm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
An Exciting New Mechanism: several reasons PCLX-001 might be a gem https://buff.ly/2PQg0pw
#cancer#precision#small#molecule#leukemia#AMLpic.twitter.com/2JHH4iJhqY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What Are the Differences Between Lymphocytic and Myelogenous Leukemia? https://buff.ly/36dbl6O
#Lymphocytic#Myelogenous#Leukemia#cancerpic.twitter.com/xUxu6w07jn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PCLX-001, qualifies for both Orphan Drug designation and Fast Track status in the US and EU https://buff.ly/2PQg0pw
#orphandrug#fasttrack#leukemia#bloodcancer#AMLpic.twitter.com/1VwjtzHI8n
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AI offers potential as diagnostic tool for acute myeloid leukemia https://buff.ly/39rsVpJ
#cancer#acute#myeloid#lukemiapic.twitter.com/LC5aFrZixp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PCLX-001 is taken orally once per day with high bioavailability providing a significant dosing and convenience advantage for patients https://buff.ly/2PQg0pw
#dosing#patient#engagement#AML#leukemiapic.twitter.com/b0PQjsaout
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Video: Pacylex Pharmaceuticals completes its 'landmark' toxicology dosing https://buff.ly/3agbLeV
#biotechshowcase#cancer#oncology#leukemiaHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Pacylex- Data from four different preclinical models suggest that PCLX-001 has robust efficacy in leukemia and lymphoma https://buff.ly/2PQg0pw
#biotechshowcase#cancer#oncology#leukemiapic.twitter.com/2GSeXsw0ja
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Phase I Human Clinical Studies - Targeting Blood Cancer with Novel Mechanism and Precision Approach Expected to Begin This Year. https://buff.ly/2PQg0pw
#blood#cancer#clinicaltrials#biotechshowcase#JPM20pic.twitter.com/IpqCXDajup
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you for a knowledge-filled conference! https://buff.ly/2PQg0pw
#JPM20#biotechshowcase#cancer#oncology#leukemiapic.twitter.com/TcZj2AWhS0
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Pacylex shared highlights about their potential gem in its pipeline this week at the Biotech Showcase. https://buff.ly/2PQg0pw
#biotechshowcase#cancer#oncology#leukemiapic.twitter.com/ocq5vkqsfl
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Pacylex Discussed new oncology targets and a drug candidate at Biotech Showcase this week. https://buff.ly/2t5kEYb
#cancer#oncology#leukemia#biotechshowcasepic.twitter.com/QWgsjkeldu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Pacylex Presenting PCLX-001 at Biotech Showcase https://buff.ly/2PQg0pw
#biotechshowcase#cancer#oncology#leukemiapic.twitter.com/2jYHzTcYyL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Pacylex Discusses new oncology target and drug candidate at Biotech Showcase - today at 4 pm PST https://buff.ly/2t5kEYb
#cancer#oncology#leukemiapic.twitter.com/s5666kaK6J
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Pacylex Discusses new oncology target and drug candidate at Biotech Showcase https://buff.ly/2t5kEYb
#cancer#oncology#leukemiapic.twitter.com/r0kVC5HIwb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Pacylex Gem: Looking forward to Biotech Showcase! https://buff.ly/2PQg0pw
#cancer#oncology#leukemiapic.twitter.com/v0bMCxpjyz
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Over $500,000 CAD was raised to support the development of Pacylex's lead drug, PCLX-001, currently on track for patient dosing next year. https://buff.ly/2PQg0pw
#cancer#precision#small#molecule#leukemia#lymphomapic.twitter.com/4VduSb72od
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Blood Cancer Symptoms and Diagnosis https://buff.ly/2SEdK6J
#cancer#precision#small#molecule#leukemia#lymphomapic.twitter.com/leq8vdFE6Y
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Pacylex Targeting Cancer with Novel Mechanism and Precision Approach
#cancer#precision#small#molecule#leukemia#lymphomapic.twitter.com/inKncRQKRP
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.